Charles Hollen has Hematology/oncology as his primary medical specialty. Their primary office is: 230 N Midwest Blvd in Midwest City, Oklahoma.
There is an additional office location, for a total of two, for Charles Hollen that can be viewed further down.
They're a part of the: Genesiscare Landmark Oklahoma Cancer Care Pc medical group which has around 19 members. You can call their office at 405-737-8455 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Oklahoma College Of Medicine and graduated in 1985 (around 39 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Charles Hollen
Genesiscare Landmark Oklahoma Cancer Care Pc
230 N Midwest Blvd
Midwest City, Oklahoma 73110
405-737-8455
Phone: 405-737-8455
Enter a starting address:
Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 1985
The Primary Medical Specialty for Charles Hollen is listed as: Hematology/oncology
Approximate Years of Experience: 39
PAC (PECOS ID)#: 3375447121
NPI #: 1205855723
NPI Created On: 07/18/2006
NPI Last Updated Listed as: 12/04/2009
Primary Taxonomy Code: 207RH0003X
License Number:
15779
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English, SPANISH, ENGLISH.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $90
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787989579
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $65
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787989581
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Payments Total: $18
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787989583
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787989585
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: BALVERSA
Associated Drug #2: 59676-030-56
Payments Total: $8
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787989587
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $15
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787989589
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $21
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 781011093
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-420-28
Payments Total: $17
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 794848385
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: VENCLEXTA
Open Associated Drug #1: 0074-0576-22
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 794848381
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: ONCOLOGY
Name of Drug #1: VENCLEXTA
Open Associated Drug #1: 0074-0576-22
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 819001745
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: VERZENIO
Open Associated Drug #1: 0002-6216-54
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: RETEVMO
Associated Drug #2: 0002-2980-60
1. Genesiscare Landmark Oklahoma Cancer Care Pc
11100 Hefner Pointe Dr
Oklahoma City, OK 73120
Suite A
Group Members: 19
Phone: 405-737-8455
Enter a starting address:
2828 N Glenhaven Dr
Midwest-city, OK
11100 Hefner Pointe Dr
Oklahoma City Ok 73120-5049
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology
4500 S Garnett Rd
Tulsa Ok 74146-5201
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology
11100 Hefner Pointe Dr
Oklahoma City Ok 73120-5049
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology
4500 S Garnett Rd
Tulsa Ok 74146-5201
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology
744 W 9th St
Tulsa Ok 74127-9907
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology
10109 E 79th St
Tulsa Ok 74133-4564
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology
View all 19 members of Genesiscare Landmark Oklahoma Cancer Care Pc medical group